Change of Nominated Adviser and Broker

Abingdon Health PLC
15 July 2024
 

 

 

 

Abingdon Health plc

 

("Abingdon Health" or "the Company")

 

Change of Nominated Adviser and Broker

 

The Company announces its Nominated Adviser and Broker has changed to Zeus Capital Limited with immediate effect.

 

This change follows completion of the acquisition by Zeus Capital Limited of the WH Ireland Capital Markets Division (from WH Ireland Limited), announced earlier today.

 

For further information please contact:

 

 

Enquiries

 

Abingdon Health plc

www.abingdonhealth.com/investors/

Chris Yates, Chief Executive Officer


Chris Hand, Non-Executive Chairman

 


Zeus Capital (Sole Broker and Nominated Adviser)

  Tel: +44 (0) 20 7220 1666

Chris Fielding / Isaac Hooper (Corporate Finance)


Fraser Marshall (Corporate Broking)


 

 

The person responsible for arranging the release of this announcement on behalf of the Company is Chris Yates, Chief Executive Officer of the Company.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Abingdon Health (ABDX)
UK 100
FTSE quotes by TradingView

Latest directors dealings

All directors dealings today